Azelis Group (AZE) Investor Lab Tour 2024 Istanbul Presentation summary
Event summary combining transcript, slides, and related documents.
Investor Lab Tour 2024 Istanbul Presentation summary
13 Jun, 2025Market overview and industry trends
Specialty chemicals and food ingredients distribution is a large, high-growth market, expanding 1.2x faster than global GDP, with a 2023 market size of €220bn and strong demand for value-added services and technical support.
The industry is highly fragmented, with over 20,000 participants, offering significant M&A opportunities and advantages for large global players.
Key megatrends include persistent volatility, regulatory and sustainability pressures, digital transformation, and a tightening global workforce.
EU-based producers face challenges from high input costs and competition from Asia, while global trade patterns are shifting.
Chemical distributors have outperformed other chemical peer groups, with distribution stocks rising 130% since 2014.
Business model and value creation
Azelis operates an asset-light, specialty-focused model diversified across multiple end-markets and geographies, serving over 63,000 customers in 65 countries.
The company creates value through formulation expertise, technical support, and a broad, innovative product portfolio, supporting both customers and principals.
Its lateral value chain enables support for innovation, regulatory compliance, and market intelligence, driving growth for principals and customers.
Azelis leverages 70+ application labs globally to drive innovation, develop new formulations, and support product launches.
Strategic pillars and growth drivers
Growth is driven by innovation, sustainability, digitalization, and active consolidation through M&A.
The IMPACT 2030 program integrates sustainability across portfolio, social, environmental, and governance pillars, aiming for industry-leading ESG performance.
A unified global digital ecosystem supports commercial excellence, operational efficiency, and enhanced customer and principal experiences.
Azelis pursues M&A to expand geographically, strengthen key segments, and fill portfolio gaps, with a proven track record of over 40 successful integrations since 2017.
Latest events from Azelis Group
- Revenue up 1.3% to €4.1bn, but net profit fell 40% as cash flow and leverage rose.AZE
H2 202519 Feb 2026 - Stable revenue, margin gains, and acquisitions amid profit and cash flow pressure.AZE
H1 20242 Feb 2026 - Q3 2024 saw organic growth and margin gains, with acquisitions driving resilient performance.AZE
Q3 2024 TU18 Jan 2026 - Revenue and margins improved in 2024, with strong M&A activity and positive outlook for 2025.AZE
H2 202425 Dec 2025 - Revenue up 4.5% to EUR 1.1bn, but margin pressure led to cost-saving measures.AZE
Q1 2025 TU29 Nov 2025 - Revenue up 0.6% to €2.2bn, profit down 14.6%, but cash flow and acquisitions boost outlook.AZE
H1 202516 Nov 2025 - Free cash flow up 34% and margin pressure, with four acquisitions and higher leverage.AZE
Q3 2025 TU23 Oct 2025